{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:31:26Z","timestamp":1767191486315,"version":"3.48.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06995"],"award-info":[{"award-number":["22K06995"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11652"],"award-info":[{"award-number":["24K11652"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K10553"],"award-info":[{"award-number":["25K10553"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K18268"],"award-info":[{"award-number":["24K18268"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bbrep.2025.102140","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T21:29:07Z","timestamp":1752614947000},"page":"102140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a novel anti-human glypican 5 monoclonal antibody (G5Mab-1) for multiple applications"],"prefix":"10.1016","volume":"43","author":[{"given":"Yu","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7984-5414","authenticated-orcid":false,"given":"Guanjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8524-7322","authenticated-orcid":false,"given":"Hiroyuki","family":"Satofuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika K.","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-5132","authenticated-orcid":false,"given":"Hiroyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5385-8201","authenticated-orcid":false,"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.102140_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0304-4165(02)00390-2","article-title":"The role of glypicans in mammalian development","volume":"1573","author":"Song","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrep.2025.102140_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/scdb.2000.0240","article-title":"Developmental roles of the glypicans","volume":"12","author":"De Cat","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1146\/annurev.biochem.68.1.729","article-title":"Functions of cell surface heparan sulfate proteoglycans","volume":"68","author":"Bernfield","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbrep.2025.102140_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1006\/geno.1999.5793","article-title":"GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13","volume":"57","author":"Paine-Saunders","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.bbrep.2025.102140_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.201008087","article-title":"Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling","volume":"192","author":"Li","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.matbio.2013.12.007","article-title":"The role of glypicans in Hedgehog signaling","volume":"35","author":"Filmus","year":"2014","journal-title":"Matrix Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12860-021-00361-x","article-title":"The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation","volume":"22","author":"de Moraes","year":"2021","journal-title":"BMC Mol. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/dbio.1997.8690","article-title":"Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain","volume":"190","author":"Saunders","year":"1997","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbrc.2006.10.185","article-title":"Glypicans are differentially expressed during patterning and neurogenesis of early mouse brain","volume":"352","author":"Luxardi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2025.102140_bib11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S1470-2045(10)70177-7","article-title":"GPC5 and lung cancer in multiple sclerosis","volume":"11","author":"Handel","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrep.2025.102140_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075416","article-title":"Multiple sclerosis susceptibility genes: associations with relapse severity and recovery","volume":"8","author":"Mowry","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.102140_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1369\/0022155420933709","article-title":"The role of glypicans in cancer progression and therapy","volume":"68","author":"Li","year":"2020","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.bbrep.2025.102140_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/geno.1996.4518","article-title":"Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family","volume":"40","author":"Veugelers","year":"1997","journal-title":"Genomics"},{"key":"10.1016\/j.bbrep.2025.102140_bib15","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","article-title":"Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma","volume":"64","author":"Ota","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102140_bib16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3892\/ol.2013.1622","article-title":"The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer","volume":"6","author":"Li","year":"2013","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrep.2025.102140_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1057>3.0.CO;2-D","article-title":"Comparative genomic hybridization detects novel amplifications in fibroadenomas of the breast","volume":"30","author":"Ojopi","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbrep.2025.102140_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1158\/0008-5472.CAN-06-1650","article-title":"Role for amplification and expression of glypican-5 in rhabdomyosarcoma","volume":"67","author":"Williamson","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102140_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/JTO.0b013e3181fd6b04","article-title":"GPC5 gene and its related pathways in lung cancer","volume":"6","author":"Li","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bbrep.2025.102140_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226538","article-title":"Subcellular localization of glypican-5 is associated with dynamic motility of the human mesenchymal stem cell line U3DT","volume":"16","author":"Takeuchi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.102140_bib21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2011.02.005","article-title":"A lung cancer gene GPC5 could also be crucial in breast cancer","volume":"103","author":"Zhang","year":"2011","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.bbrep.2025.102140_bib22","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1007\/s13277-015-4499-3","article-title":"Prognostic significance of GPC5 expression in patients with prostate cancer","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2019.03.057","article-title":"MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt\/\u03b2-catenin signaling via targeting Glypican-5","volume":"854","author":"Hong","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrep.2025.102140_bib24","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/cpr.12288","article-title":"miR-297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma","volume":"49","author":"Sun","year":"2016","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrep.2025.102140_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3727\/096504017X15044461944385","article-title":"Overexpression of Glypican 5 (GPC5) inhibits prostate cancer cell proliferation and invasion via suppressing Sp1-Mediated EMT and activation of Wnt\/\u03b2-Catenin signaling","volume":"26","author":"Sun","year":"2018","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbrep.2025.102140_bib26","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/s41388-021-01837-y","article-title":"GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1\/AhR\/ARNT signaling axis and extracellular exosome secretion","volume":"40","author":"Yang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.102140_bib27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.canlet.2013.08.020","article-title":"Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer","volume":"341","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrep.2025.102140_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(10)70042-5","article-title":"Genetic variants and risk of lung cancer in never smokers: a genome-wide association study","volume":"11","author":"Li","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrep.2025.102140_bib29","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/onc.2016.149","article-title":"GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt\/\u03b2-catenin signaling in lung adenocarcinoma","volume":"35","author":"Yuan","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.102140_bib30","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.3892\/mmr.2014.2092","article-title":"GPC5, a tumor suppressor, is regulated by miR-620 in lung adenocarcinoma","volume":"9","author":"Zhao","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrep.2025.102140_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cpr.12181","article-title":"miR-709 up-regulated in hepatocellular carcinoma, promotes proliferation and invasion by targeting GPC5","volume":"48","author":"Liu","year":"2015","journal-title":"Cell Prolif."},{"key":"10.1016\/j.bbrep.2025.102140_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/mab.2018.0004","article-title":"Monoclonal antibody L(1)Mab-13 detected human PD-L1 in lung cancers","volume":"37","author":"Yamada","year":"2018","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.102140_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/mab.2023.0018","article-title":"A rat anti-mouse CD39 monoclonal antibody for flow cytometry","volume":"42","author":"Suzuki","year":"2023","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.bbrep.2025.102140_bib34","article-title":"Development of a novel Anti-EpCAM monoclonal antibody for various applications","volume":"11","author":"Li","year":"2022","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.bbrep.2025.102140_bib35","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8083","article-title":"An anti-TROP2 monoclonal antibody TrMab-6 exerts antitumor activity in breast cancer mouse xenograft models","volume":"46","author":"Tanaka","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrep.2025.102140_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.pep.2014.01.009","article-title":"PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin","volume":"95","author":"Fujii","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbrep.2025.102140_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10014-015-0222-8","article-title":"Evaluation of IDH1 status in diffusely infiltrating gliomas by immunohistochemistry using anti-mutant and wild type IDH1 antibodies","volume":"32","author":"Ikota","year":"2015","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.bbrep.2025.102140_bib38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cjp2.89","article-title":"Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas","volume":"4","author":"Chui","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.bbrep.2025.102140_bib39","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5221","article-title":"Antitumor activities of a defucosylated anti-EpCAM monoclonal antibody in colorectal carcinoma xenograft models","volume":"51","author":"Li","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrep.2025.102140_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/cas.16008","article-title":"Antitumor activities against breast cancers by an afucosylated anti-HER2 monoclonal antibody H(2) Mab-77-mG(2a) -f","volume":"115","author":"Tanaka","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2025.102140_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031941","article-title":"A cancer-specific monoclonal antibody against HER2 exerts antitumor activities in human breast cancer xenograft models","volume":"25","author":"Kaneko","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2025.102140_bib42","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1078-0432.CCR-12-2616","article-title":"First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma","volume":"19","author":"Zhu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102140_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cas.12368","article-title":"Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma","volume":"105","author":"Ikeda","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbrep.2025.102140_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jhep.2016.04.004","article-title":"Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma","volume":"65","author":"Abou-Alfa","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrep.2025.102140_bib45","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-19-3259","article-title":"Chimeric antigen Receptor-Glypican-3 T-Cell therapy for advanced hepatocellular carcinoma: results of phase I trials","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102140_bib46","doi-asserted-by":"crossref","first-page":"26968","DOI":"10.1074\/jbc.274.38.26968","article-title":"Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans","volume":"274","author":"Veugelers","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.102140_bib47","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling","volume":"65","author":"Capurro","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102140_bib48","doi-asserted-by":"crossref","first-page":"6536","DOI":"10.1038\/ncomms7536","article-title":"Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis","volume":"6","author":"Gao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2025.102140_bib49","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.devcel.2008.03.006","article-title":"Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding","volume":"14","author":"Capurro","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrep.2025.102140_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/dbio.2000.0127","article-title":"Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis","volume":"231","author":"Grisaru","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib51","doi-asserted-by":"crossref","first-page":"22991","DOI":"10.1074\/jbc.M115.660878","article-title":"Structural aspects of N-Glycosylations and the C-terminal Region in Human Glypican-1","volume":"290","author":"Awad","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.102140_bib52","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1083\/jcb.200302152","article-title":"Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements","volume":"163","author":"De Cat","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrep.2025.102140_bib53","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-anchem-071024-124203","article-title":"Decoding extracellular protein glycosylation in human health and disease","author":"Steigmeyer","year":"2025","journal-title":"Annu. Rev. Anal. Chem. (Palo Alto Calif)"},{"key":"10.1016\/j.bbrep.2025.102140_bib54","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1038\/srep05924","article-title":"A cancer-specific monoclonal antibody recognizes the aberrantly glycosylated Podoplanin","volume":"4","author":"Kato","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102140_bib55","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.str.2024.02.007","article-title":"Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies","volume":"32","author":"Arimori","year":"2024","journal-title":"Structure"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825002274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825002274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:29:23Z","timestamp":1767191363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825002274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"alternative-id":["S2405580825002274"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102140","relation":{},"ISSN":["2405-5808"],"issn-type":[{"type":"print","value":"2405-5808"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel anti-human glypican 5 monoclonal antibody (G5Mab-1) for multiple applications","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102140"}}